TAMPA, Fla., July 13, 2016 /PRNewswire/ -- CareDx, Inc. (NASDAQ: CDNA), a molecular diagnostics company, today called for Medicare Administrative Contractor First Coast Service Options, Inc. to reverse its recent proposal to drastically reduce reimbursement for its FDA-cleared diagnostic test AlloMap, which measures gene expression levels to help clinicians determine a heart transplant recipient's risk for organ rejection. 

A coalition of physicians, health policy experts and interest groups called on HHS to set up more mandatory pilot programs to test out bundled payment models within Medicare.

Objective Medical Systems and White Plume Technologies combine EHR and charge capture for advanced interface connectivity, increased efficiency.

International Board Raises Global Awareness of the Value of IBHRE. 

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. commercial availability of MiniMed Connect, the first and only product to enable people with diabetes to discreetly and conveniently view their insulin pump and continuous glucose monitoring (CGM) information on a smartphone.

LOS ANGELES (March 27, 2014) – Two Cedars-Sinai Heart Institute physician-researchers have been named recipients of prestigious awards from the American College of Cardiology.

More than 2,000 experts in the field of cardiology will join together at this year's three-day American College of Cardiology 46th New York Cardiovascular Symposium from December 13-15 in New York City. The event, which is one of the most prestigious cardiology events in the world, will review and highlight the latest advances in cardiology for 2013 and the next big things to expect in cardiology in 2014.

Gov. Rick Perry today announced a $3 million investment through the Texas Emerging Technology Fund (TETF) to create the Center for Cell and Organ Biotechnology in collaboration with the Texas Heart Institute (THI) and Texas A&M University College of Veterinary Medicine and Biomedical Sciences.